Can I use direct oral anticoagulants to treat cancer-associated venous thromboembolism?
2020
Yes. The direct oral anticoagulants rivaroxaban, edoxaban, and apixaban have been studied in cancer-associated venous thromboembolism and are increasingly replacing low-molecular-weight heparins such as dalteparin and enoxaparin for this purpose. Individualizing care by balancing risks and benefits
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
9
References
0
Citations
NaN
KQI